This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
jarmoluk / Pixabay

This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?

According to a story from Forbes, a new drug developed by the company Regeneron has the potential to make a real difference for people with the homozygous form of familial…

Continue Reading This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease
katicaj / Pixabay

A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease

According to a story from rheumatology.medicinematters.com, a recent Italian real-world study has provided some evidence that the drug apremilast, which is considered a phosphodiesterase-4 inhibitor, could be a useful treatment…

Continue Reading A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease